patent expirations

Surescripts settlement commentary

Pharma

Gilead inks Biktarvy settlements with 3 generic drug makers

Thanks to new settlements with a trio of generic drug makers, Gilead Sciences has extended the expected life span of its lucrative HIV treatment.

Fraiser Kansteiner Oct 7, 2025 7:40am

Realistic white price tags collection Special offer or shopping discount label

Fierce Biotech

China biotechs ‘reshaping’ US biopharma: Jefferies report

Jul 14, 2025 2:30pm

Takeda

JPM25: Takeda touts 6 pipeline assets with big sales potential

Jan 15, 2025 3:17pm

European Commission EU Europe Brussels EC

Teva hit with €463M fine over Copaxone misconduct claims in EU

Oct 31, 2024 10:45am

clock time

'The Top Line': 2023's exclusivity losses, this week's news

Apr 7, 2023 7:30am

time clock

The top 10 drug patent expirations of 2023

Mar 13, 2023 3:00am